188 related articles for article (PubMed ID: 8577709)
21. E expression is needed on both bone marrow derived cells and thymic epithelium to increase IL-4 production and achieve protection in NOD bone marrow chimeras.
Brenden N; Rietz C; Böhme J
Cytokine; 1999 Oct; 11(10):766-72. PubMed ID: 10525315
[TBL] [Abstract][Full Text] [Related]
22. Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.
de Jersey J; Snelgrove SL; Palmer SE; Teteris SA; Mullbacher A; Miller JF; Slattery RM
Proc Natl Acad Sci U S A; 2007 Jan; 104(4):1295-300. PubMed ID: 17229843
[TBL] [Abstract][Full Text] [Related]
23. Local production of human IL-6 promotes insulitis but retards the onset of insulin-dependent diabetes mellitus in non-obese diabetic mice.
DiCosmo BF; Picarella D; Flavell RA
Int Immunol; 1994 Dec; 6(12):1829-37. PubMed ID: 7696203
[TBL] [Abstract][Full Text] [Related]
24. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice.
French MB; Allison J; Cram DS; Thomas HE; Dempsey-Collier M; Silva A; Georgiou HM; Kay TW; Harrison LC; Lew AM
Diabetes; 1997 Jan; 46(1):34-9. PubMed ID: 8971078
[TBL] [Abstract][Full Text] [Related]
25. A family of hsp60-related proteins in pancreatic beta cells of non-obese diabetic (NOD) mice.
Brudzynski K; Cunningham IA; Martinez V
J Autoimmun; 1995 Dec; 8(6):859-74. PubMed ID: 8824711
[TBL] [Abstract][Full Text] [Related]
26. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
27. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
[TBL] [Abstract][Full Text] [Related]
28. Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium.
Serreze DV; Leiter EH
J Immunol; 1991 Aug; 147(4):1222-9. PubMed ID: 1869820
[TBL] [Abstract][Full Text] [Related]
29. Unexpected acceleration of type 1 diabetes by transgenic expression of B7-H1 in NOD mouse peri-islet glia.
Yantha J; Tsui H; Winer S; Song A; Wu P; Paltser G; Ellis J; Dosch HM
Diabetes; 2010 Oct; 59(10):2588-96. PubMed ID: 20522597
[TBL] [Abstract][Full Text] [Related]
30. Disease-protected major histocompatibility complex Ea-transgenic non-obese diabetic (NOD) mice show interleukin-4 production not seen in susceptible Ea-transgenic and non-transgenic NOD mice.
Brenden N; Böhme J
Immunology; 1998 Sep; 95(1):1-7. PubMed ID: 9767450
[TBL] [Abstract][Full Text] [Related]
31. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
[TBL] [Abstract][Full Text] [Related]
32. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
Lühder F; Katz J; Benoist C; Mathis D
J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
[TBL] [Abstract][Full Text] [Related]
33. The effect of bone marrow and thymus chimerism between non-obese diabetic (NOD) and NOD-E transgenic mice, on the expression and prevention of diabetes.
Parish NM; Chandler P; Quartey-Papafio R; Simpson E; Cooke A
Eur J Immunol; 1993 Oct; 23(10):2667-75. PubMed ID: 8405065
[TBL] [Abstract][Full Text] [Related]
34. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells.
Pane JA; Webster NL; Zufferey C; Coulson BS
Virus Res; 2014 Jan; 179():73-84. PubMed ID: 24246305
[TBL] [Abstract][Full Text] [Related]
35. Acceleration of spontaneous diabetes in TCR-beta-transgenic nonobese diabetic mice by beta-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-alpha chains.
Verdaguer J; Yoon JW; Anderson B; Averill N; Utsugi T; Park BJ; Santamaria P
J Immunol; 1996 Nov; 157(10):4726-35. PubMed ID: 8906855
[TBL] [Abstract][Full Text] [Related]
36. Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes.
Lesage S; Hartley SB; Akkaraju S; Wilson J; Townsend M; Goodnow CC
J Exp Med; 2002 Nov; 196(9):1175-88. PubMed ID: 12417628
[TBL] [Abstract][Full Text] [Related]
37. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides.
Abulafia-Lapid R; Elias D; Raz I; Keren-Zur Y; Atlan H; Cohen IR
J Autoimmun; 1999 Mar; 12(2):121-9. PubMed ID: 10047432
[TBL] [Abstract][Full Text] [Related]
38. MHC-linked protection from diabetes dissociated from clonal deletion of T cells.
Böhme J; Schuhbaur B; Kanagawa O; Benoist C; Mathis D
Science; 1990 Jul; 249(4966):293-5. PubMed ID: 2115690
[TBL] [Abstract][Full Text] [Related]
39. Progression to diabetes in nonobese diabetic (NOD) mice with transgenic T cell receptors.
Lipes MA; Rosenzweig A; Tan KN; Tanigawa G; Ladd D; Seidman JG; Eisenbarth GS
Science; 1993 Feb; 259(5098):1165-9. PubMed ID: 8267690
[TBL] [Abstract][Full Text] [Related]
40. T cells are unresponsive to transgenic MHC class II molecules expressed on pancreatic beta cells.
Pilström B; Böhme J
Scand J Immunol; 1997 Apr; 45(4):361-5. PubMed ID: 9105422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
